Beef Prices: Blame the Packers, Not America’s Ranchers
KEY POINTS Beef prices are at record highs—not because of U.S. ranchers or tariffs, but because dependence on foreign imports and meatpacker consolidation have distorted
CPA Releases New Economics Report on America’s Chip-for-Chip Tariff Policy
The report, titled “America’s Chip-for-Chip Tariff Policy: The Urgent Fight to Reclaim Industrial Independence Before It’s Too Late,” finds that the United States now produces only 10 percent of the world’s chips—and almost none of the most advanced ones—while China has captured the majority of global capacity for legacy chips, the mature semiconductors essential to cars, medical devices, and industrial equipment.
New CPA Economic Report on ‘The New Biotech Cold War’
Titled “The New Biotech Cold War: The U.S. Medicine Can’t Afford to Fall Behind China,” the report shows how U.S. biotech – long a pillar of national strength – no longer has a guaranteed edge globally.
New CPA Economic Report Focuses on Growing Crisis for American Shipbuilding Industry
The U.S. Shipbuilding Base has Withered Since the 80s; Latest CPA Report Examines What’s Needed to Bring it Back
Tariffs Are Not Causing Inflation: Breaking Down August 2025 CPI
The August 2025 inflation report has reignited debate over tariffs. Some pundits have been quick to blame trade policy for rising prices, invoking Smoot-Hawley comparisons and warning of disaster on the scale of the Great Depression. But the data tells a different story.
Torsekar: Defending America’s Copper Mills Will Take More Than Tariffs
Data centers powering AI need copper wiring and transformers. EVs use nearly four times more copper than gas-powered cars. Wind turbines, solar farms and the modern electric grid all depend on it. As such, copper is a building block of tomorrow’s economy and the backbone of America’s national security.
The Price Impact of Generic Drug Tariffs: Why Patients Do Not Bear the Cost
America is dangerously reliant on high-risk foreign suppliers for essential generic drugs, especially APIs concentrated in China and India. That over-reliance has already triggered preventable crises, such as nationwide chemotherapy shortages when a single overseas plant shut down.
Rechenberg: Why the United States Should Not Renew AGOA
The African Growth and Opportunity Act (AGOA), enacted in 2000, was designed to promote economic development and democratic reform in Sub-Saharan Africa by granting duty-free access to the U.S. market for thousands of products.
Restoring America’s Generic Drug Independence
America’s generic drug supply is at a crisis point. As detailed in previous reports, the United States is dangerously reliant on a high-risk imported drug supply, and today’s widespread drug shortages stem not from shipping delays or unexpected demand—but from a collapse in domestic production.
Trade Agreements: The Export Myth That Masked a National Giveaway
For decades, U.S. politicians have sold free trade agreements as a beacon of prosperity for the American economy. The logic was tidy: “Most of the world’s consumers live outside the U.S.—so if we open foreign markets, prosperity will follow.” On paper, it sounded plausible. But in practice, it became one of the most costly economic miscalculations in our modern history.
